Home » Topics » BioWorld Science

BioWorld Science
RSS

Amgen describes new PRMT5 inhibitors

July 15, 2022

Zydus Lifesciences identifies new PCSK9 inhibitors

July 15, 2022

GlaxoSmithKline synthesizes new Nav1.8 channel blockers

July 15, 2022

Pandeia Therapeutics patents new GPR88 agonists

July 15, 2022

Chiesi Farmaceutici discloses new ROCK inhibitors

July 15, 2022

miR-411-5p is a predictor of MACE in patients with atrial fibrillation

July 15, 2022

Reduced sensitivity to aspirin by MRP4 may explain ACS risk

July 15, 2022

KDM4B enzyme inhibitor tested for aggressive rhabdomyosarcoma

July 14, 2022

CytomX restructures and outlines plans for preclinical pipeline

July 14, 2022

FDA awards orphan drug designation to AVR-RD-05 for Hunter's syndrome

July 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...